NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 71 filers reported holding NOVELION THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,000 | -97.6% | 1,100 | -96.7% | 0.00% | – |
| Q2 2018 | $124,000 | +1027.3% | 33,720 | +963.4% | 0.00% | – |
| Q1 2018 | $11,000 | +57.1% | 3,171 | +41.8% | 0.00% | – |
| Q4 2017 | $7,000 | – | 2,237 | +74466.7% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 3 | -99.9% | 0.00% | – |
| Q2 2017 | $45,000 | -13.5% | 4,911 | -0.1% | 0.00% | – |
| Q1 2017 | $52,000 | -36.6% | 4,915 | -49.4% | 0.00% | – |
| Q4 2016 | $82,000 | – | 9,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|